Login to Your Account



Pharma: Other news to note


Friday, January 24, 2014
The FDA prohibited Ranbaxy Laboratories Ltd., from manufacturing and distributing active pharmaceutical ingredients (API) from its facility in Toansa, India, for FDA-regulated drug products, making the Toansa facility subject to certain terms of a consent decree of permanent injunction entered against the pharma in January 2012.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription